Douglas Fisher

Douglas Fisher is a declared insider at 2 companies (chief executive); the most frequent names are Cero Therapeutics Holdings, Inc. and ReShape Lifesciences Inc. In total, 2 filings cover trades dated from 23 July 2019 to 8 October 2021.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Most recently, on 12 October 2021, the filings show a transaction in Cero Therapeutics Holdings, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.